Implementation for tuberculosis preventive therapy among latent tuberculosis infection in HIV-infected individuals using novel regimen of Isoniazid/Rifapentine daily (4 weeks) compared to Isoniazid/Rifapentine weekly (12 weeks)

This study is a multicenter, randomized, open-label, phase III clinical trial of INH/RPT (Isoniazid/Rifapentine) regimen administered…

Bictegravir/TAF/FTC in HIV/HBV co-infection

Description: n/a

Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase III clinical trial

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis…

Human papillomavirus infection in perinatally HIV-infected adolescents in Asia

This is a longitudinal case-control study to monitor a cohort of perinatally HIV-infected and matched HIV–uninfected…

BioBank for Surrogate Marker Research for TB (B-SMART)

This protocol serves two purposes: To collect and store relevant biological specimens for repository biobanking to…

Efficacy and liver fibrosis improvement in compensated cirrhotic patients with chronic HCV genotypes 1 and 6 infection with and without HIV co-infection receiving the combination regimen of Grazoprevir and Elbasvir

This study will evaluate the safety and efficacy of combination treatment with grazoprevir + elbasvir for…

Cross-sectional study examining the prevalence rate and determinants of frailty in the HIV positive and negative Thai populations

This is a cross-sectional study examining the prevalence rate and determinants of frailty in the HIV…

Liver disease progression in HIV/HBV co-infection SOFIA: cross-sectional cohort

This is a cross-sectional, international multi-site cohort study to investigate the relationship between changes on liver…

An international observational study to characterize adults who are hospitalized with complications of influenza A – pandemic H1N1 (H1N1v)

The purpose of this observational study is to describe the characteristics and outcomes over a 60-day…

Maintenance of switching from Protease Inhibitor/Ritonavir to generic single tablet regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir in virologically suppressed HIV-infected adults

The fundamental principle of regimen switching is to maintain viral suppression without jeopardizing future treatment options.

A phase IIIb, randomized, open-label study of the safety and efficacy of Dolutegravir/Abacavir/Lamivudine once daily compared to Atazanavir and Ritonavir plus Tenofovir/Emtricitabine once daily in HIV-1 infected antiretroviral therapy naïve women

This study is designed to demonstrate the non-inferior antiviral activity of DTG/ABC/3TC fixed dose combination (FDC)…

Treatment outcome of children with HIV infection treated with highly active antiretroviral therapy (HAART)

This is a long-term follow-up study of safety and efficacy of antiretroviral therapy for HIV positive…